Abstract
Introduction/BackgroundHigh-grade serous ovarian cancer (HGSOC) is typified by extensive genomic instability and intra-tumoural heterogeneity (ITH). Most patients relapse and eventually acquire resistance to platinum- or PARP inhibitor-based therapy. Diverse mechanisms...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have